Tuberculosis Trial, Recruiting NCT05285202 Sponsor: Johns Hopkins University Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT05285202
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 15 years or older, OR children aged 5 to 14 years who have been in close contact with someone diagnosed with tuberculosis (TB)
  • People who are able to give spoken agreement to take part — or, for children under 18 who are not legally independent, a parent or guardian must give spoken consent (for children aged 5 to 17), and the child themselves must also agree if they are aged 8 to 17
  • People who can communicate in English or Luganda, or who have access to a suitable interpreter they are comfortable with

Who may not be able to join:

  • People who are currently being treated for active TB, or who have been diagnosed with active TB but have not yet started treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Emily Kendall, MD PhD, Johns Hopkins University

Phone: 410-502-8234

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2022
Est. completion
1 August 2026

Where this trial is recruiting

Uganda

Primary endpoints

Pulmonary bacteriologically confirmed TB notifications, hotspot vs facility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov